Newsummitbio
Shanghai
About Newsummitbio
Shanghai Newsummit Biopharma is a Chinese provider of comprehensive pharmaceuticals industrialization, modularization, standardization, and large-scale R&D services. Newsummit is focused on the optimization and integration of industrial resources through the alliance of governance, production, education, research and capital, to serve scientists, entrepreneurs, investors, and the government. These services include assisting the scientists to facilitate the achievements of new medicine and realize the industrialization; providing entrepreneurs with achievements with industrial value and industry incubation; helping investors to shorten investment cycle and reduce investment risk; serving the government by integrating resources from China's New Medicines Public Service Platform; and strengthening the international competitiveness of China's New Medicines' self-research and development.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jan 2011)
- Website: newsummitbio.com
- Phone: 86 21 5079 8788
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/newsummitbio-2282241 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.